Elite Pharmaceuticals's total assets for Q1 2026 were $111.34M, an increase of 15.51% from the previous quarter. ELTP total liabilities were $63.66M for the fiscal quarter, a 48.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.